- Conditions
- Alpha 1 Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
- Locations
-
- GC2501 Study Site 106 Birmingham, Alabama, United States
- GC2501 Study Site 102 Phoenix, Arizona, United States
- GC2501 Study Site 107 Scottsdale, Arizona, United States
- GC2501 Study Site 100 Los Angelas, California, United States
Clinical trial condition
Subcutaneous Emphysema
Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Subcutaneous Emphysema trial results
NCT07431112
- Conditions
- Alpha 1 Antitrypsin Deficiency, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
- Locations
-
- Clinical Study Center Melbourne, Australia
- Clinical Study Center 1 Tbilisi, Georgia
- Clinical Study Center 2 Tbilisi, Georgia
- Clinical Study Center Cambridge, United Kingdom
NCT05963945
- Conditions
- Atelectasis, Cardiomegaly, Cardiovascular Diseases, +16 more
- Locations
-
- Nemocnice Havířov, p. o. Havířov, Czechia
NCT04722887
- Conditions
- Alpha1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
- Locations
-
- UCLA Medical Center Los Angeles, California, United States
- University of Florida Gainesville, Florida, United States
- University of Miami Miami, Florida, United States
- Cleveland Clinic Cleveland, Ohio, United States
NCT04840953
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +14 more
- Locations
-
- Hospital General Universitario de Elche Elche, Alicante, Spain